Oryzon to invest eur 20 million to develop new drugs
Catalan Economy
10 Sep 2009
Biotech company oryzon genomics has announced a four-year program to invest eur 20 million in the development of new drugs. oryzon ceo carlos buesa indicated that the company would use the resources to strengthen its research on biomarkers and antibody therapy.
oryzon recently opened its new 2,300-square-meter corporate headquarters in cornellà de llobregat (barcelona), with an investment of eur 2.5 million. the company expects revenue of eur 8 million for its current fiscal year.
source: expansión catalunya, 08/09/09
Related News and Success stories.
-
23 Oct 2024
Catalonia is home to 9,602 foreign companies, a record high and a 68% increase over the past decade
-
17 Oct 2024
A group of 20 Catalan clusters travel to China to explore innovation opportunities and build alliances
-
15 Oct 2024
LCI Education invests €33 million in a new European hub in Barcelona
-
30 Sep 2024
Cluster participation in Catalonia rises 30%, hitting a record of 3,000 companies